By comparing the P42 parameter among the groups, a highly significant difference was observed between AD (0.83 [0.58–1.16] A.U.]) and non-AD samples from NC individuals (0.42 [0.09–0.69] A.U.]), or NADD patients (0.42 [0.04–0.74] A.U.).
← all excerpts
Detection of plasma Aβ seeding activity by a newly developed analyzer for diagnosis of Alzheimer's disease.
1
—
—